机译:吉非替尼一线治疗后铂类联合化疗对具有敏感EGFR突变的非小细胞肺癌患者的疗效
Department of Medicine and Molecular Science Gunma University Graduate School of Medicine">(1);
Department of Medicine and Molecular Science Gunma University Graduate School of Medicine">(1);
Department of Medicine and Molecular Science Gunma University Graduate School of Medicine">(1);
Department of Respiratory Medicine Gunma Prefectural Cancer Center">(2);
Division of Respiratory Medicine National Hospital Organization Nishigunma Hospital">(3);
Department of Oncology Clinical Development Gunma University Graduate School of Medicine">(4);
Department of Thoracic and Visceral Organ Surgery Gunma University Graduate School of Medicine">(5);
Department of Medicine and Molecular Science Gunma University Graduate School of Medicine">(1);
Division of Respiratory Medicine National Hospital Organization Nishigunma Hospital">(3);
Division of Internal Medicine Isesaki Municipal Hospital">(6);
Department of General Surgical Science Gunma University Graduate School of Medicine">(7);
Department of Medicine and Molecular Science Gunma University Graduate School of Medicine">(1);
Department of Respiratory Medicine Gunma Prefectural Cancer Center">(2);
Division of Respiratory Medicine Maebashi Red Cross Hospital">(8);
Division of Respiratory Medicine National Hospital Organization Nishigunma Hospital">(3);
Department of Medicine and Molecular Science Gunma University Graduate School of Medicine">(1);
Advanced non-small cell lung cancer; EGFR mutations; Gefitinib; Non-small cell lung cancer; Second-line platinum-based chemotherapy;
机译:吉非替尼一线治疗后铂类联合化疗对具有敏感EGFR突变的非小细胞肺癌患者的疗效
机译:吉非替尼联合培美曲塞联合方案作为一线治疗患有EGFR突变的晚期非小细胞肺癌患者的二期研究
机译:患有敏感EGFR突变的老年非小细胞肺癌患者患者患者中的细胞毒性药物化疗疗效和安全性
机译:接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
机译:评估姑息化疗对非小细胞肺癌的有效性:在安大略省癌症中心接受治疗的患者的IV期研究
机译:吸烟状态在非小细胞肺癌患者无进展生存中的作用该患者具有接受一线EGFR酪氨酸激酶抑制剂对铂类双重化疗的活化表皮生长因子受体(EGFR)突变:前瞻性随机试验的Meta分析。
机译:第一代EGFR-TKI的疗效和安全性联合化疗治疗治疗 - 幼稚高级非小细胞肺癌患者,涉及敏感EGFR突变:单中心,开放标签,单臂,II期临床试验